COMPASS Pathways plc

Nasdaq:CMPS

Pharmaceutical Preparations·CHESIRE, X0

Compass Pathways, or COMPASS Pathways, is a British pharmaceutical company developing psychedelics as potential medicines. Its main drug candidate, psilocybin (COMP360), is currently in phase 3 clinical trials for treatment-resistant depression.

CEO

Nath Kabir

CFO

Loxam Teri

Financials

16 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/4/25	→
10-Q	Q2 2025	6/30/25	7/31/25	→
10-Q	Q1 2025	3/31/25	5/8/25	→
10-K	FY 2024	12/31/24	2/27/25	→
10-Q	Q3 2024	9/30/24	10/31/24	→
10-Q	Q2 2024	6/30/24	8/1/24	→
↓

Earnings Releases (8-K)

14 shown

Filed	Period
11/4/25	Q4 FY2025	→
7/31/25	Q2 FY2025	→
5/8/25	Q2 FY2025	→
2/27/25	Q1 FY2025	→
10/31/24	Q3 FY2024	→
8/1/24	Q2 FY2024	→
↓

News (8-K)

29 shown

Filed	Type	Description
2/19/26	Agreement	Entry into a Material Definitive Agreement	→
2/17/26	Reg FD	Regulation FD Disclosure	→
1/7/26	Agreement	Entry into a Material Definitive Agreement	→
10/29/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
7/29/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
6/23/25	Other	Other Events	→
↓

Prospectuses & Registrations

32 shown

Filed	Form	Description
2/19/26	424B5	424B5	→
2/17/26	424B5	424B5	→
5/8/25	424B5	424B5	→
4/28/25	ARS	ARS	→
2/27/25	S-8	S-8	→
2/27/25	S-3	S-3	→
↓

Filing History(312 filings)

TypeDateAccessionPeriodSize

Mar 13, 2026

0001940258-26-000006FORM 4

Mar 11, 2026

4.9 KB

Mar 13, 2026

0001829111-26-000004FORM 4

Mar 11, 2026

5.0 KB

Mar 3, 2026

0001829111-26-000002FORM 4

Mar 2, 2026

5.0 KB

8-K

Feb 19, 2026

0001628280-26-0095018-K

Feb 18, 2026

1004.2 KB

424B5

Feb 19, 2026

0001628280-26-009499424B5

—

953.7 KB

SCHEDULE 13D/A

Feb 17, 2026

0001140361-26-005810

—

9.5 KB

424B5

Feb 17, 2026

0001628280-26-008567424B5

—

951.8 KB

8-K

Feb 17, 2026

0001816590-26-0000078-K

Feb 17, 2026

5.0 MB

Feb 3, 2026

0001940258-26-000004FORM 4

Feb 2, 2026

4.9 KB

8-K

Jan 7, 2026

0001816590-26-0000048-K

Jan 5, 2026

1004.4 KB

SCHEDULE 13G/A

Nov 14, 2025

0001213900-25-111136

—

15.7 KB

SCHEDULE 13G/A

Nov 14, 2025

0001104659-25-112650

—

10.7 KB

10-Q

Nov 4, 2025

0001816590-25-00015010-Q

Sep 30, 2025

5.5 MB

8-K

Nov 4, 2025

0001816590-25-0001498-K

Nov 4, 2025

301.0 KB

Oct 31, 2025

0001042021-25-000005FORM 4

Oct 29, 2025

5.6 KB

Oct 31, 2025

0001816590-25-000144FORM 3

Oct 29, 2025

419.9 KB

SCHEDULE 13D/A

Oct 29, 2025

0001140361-25-039738

—

8.1 KB

8-K

Oct 29, 2025

0001816590-25-0001418-K

Oct 26, 2025

166.6 KB

SCHEDULE 13G/A

Aug 14, 2025

0001415889-25-021984

—

10.7 KB

SCHEDULE 13G/A

Aug 14, 2025

0000950170-25-109053

—

19.3 KB

SCHEDULE 13G

Aug 14, 2025

0001104659-25-078711

—

10.7 KB

Aug 4, 2025

0001816590-25-000106FORM 4

Aug 1, 2025

4.9 KB

8-K

Jul 31, 2025

0001816590-25-0001038-K

Jul 31, 2025

302.8 KB

10-Q

Jul 31, 2025

0001816590-25-00010210-Q

Jun 30, 2025

10.0 MB

Jul 30, 2025

0001816590-25-000099FORM 4

Jul 29, 2025

5.5 KB

25 filings shown

Filed	Form	Description
4/28/25	DEF 14A	DEF 14A	→
4/16/25	PRE 14A	PRE 14A	→
4/8/24	DEF 14A	DEF 14A	→
3/28/24	PRE 14A	PRE 14A	→
4/19/23	DEF 14A	DEF 14A	→
4/28/22	DEF 14A	DEF 14A	→

COMPASS Pathways plc

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(312 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
3/13/26	4	4	→
3/13/26	4	4	→
3/3/26	4	4	→
2/3/26	4	4	→
10/31/25	4	4	→
10/31/25	3	FORM 3	→
↓